Duodenal pulsENDO as an Early Treatment for Type 2 DM
Duodenal pulsENDO as an Early Treatment for Type 2 DM
Recruiting · NCT07376486 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Duodenal pulsENDO as an Early Treatment for Type 2 DM | Digestive System Diseases, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease | Recruiting | Not applicable | 2026-09-15 | NCT07376486 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chinese University of Hong Kong | 480 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese University of Hong Kong | Shatin | Hong Kong | 8 |